Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants
Author:
Affiliation:
1. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States
Funder
National Center for Advancing Translational Sciences
National Institutes of Health
Publisher
American Chemical Society (ACS)
Subject
Pharmacology (medical),Pharmacology
Link
https://pubs.acs.org/doi/pdf/10.1021/acsptsci.1c00176
Reference55 articles.
1. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin | Nature. https://www.nature.com/articles/s41586-020-2012-7 (accessed Aug 28, 2021).
2. COVID-19 Data in Motion. https://coronavirus.jhu.edu/ (accessed May 5, 2021).
3. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19
4. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
5. Anti-SARS and anti-HCV drugs repurposing against the Papain-like protease of the newly emerged coronavirus (2019-nCoV)
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case;Microbiology Spectrum;2024-08-06
2. Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking;International Journal of Molecular Sciences;2024-05-01
3. Machine learning and protein allostery;Trends in Biochemical Sciences;2023-04
4. Targeting Virus-Induced Reprogrammed Cell Metabolism via Glycolytic Inhibitors: An Effective Therapeutic Approach Against SARS-CoV-2;Mini-Reviews in Medicinal Chemistry;2023-02
5. Chronic Lung and Respiratory Conditions Affecting Lungs and Airways;ACS Pharmacology & Translational Science;2022-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3